Free Trial

NovaBay Pharmaceuticals (NBY) SEC Filings & 10K Form

→ These AI trades triggered this morning (545% return) (From Prosper Trading Academy) (Ad)
Free NBY Stock Alerts
$0.08
0.00 (0.00%)
(As of 04/26/2024 ET)
Compare
Stock AnalysisChartEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort Interest

Recent NovaBay Pharmaceuticals SEC Filings

Export to Excel
DateFilerForm TypeView
04/22/2024
5:04 AM		NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/19/2024
4:21 PM		NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/18/2024
8:15 AM		NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form ARS
04/18/2024
8:00 AM		NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form DEF 14A
04/18/2024
8:06 AM		NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form DEFA14A
04/08/2024
3:15 PM		NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form PRE 14A
04/05/2024
11:27 AM		NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form D
Notice of Exempt Offering of Securities 
03/29/2024
10:00 AM		NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form 10-K/A
03/26/2024
3:14 PM		NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/26/2024
6:30 AM		NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/25/2024
6:30 AM		NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/14/2024
7:30 AM		NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2024
1:52 PM		ARMISTICE CAPITAL, LLC (Filed by)
NovaBay Pharmaceuticals (Subject)
NovaBay Pharmaceuticals, Inc. (Subject)
Form SC 13G/A
02/06/2024
10:52 AM		Hudson Bay Capital Management LP (Filed by)
NovaBay Pharmaceuticals (Subject)
NovaBay Pharmaceuticals, Inc. (Subject)
Form SC 13G/A
01/10/2024
7:00 AM		NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/04/2024
10:50 AM		NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form D
Notice of Exempt Offering of Securities 
12/21/2023
6:58 AM		NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/11/2023
3:32 PM		NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/07/2023
4:00 PM		NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/06/2023
4:00 PM		NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/14/2023
3:45 PM		NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/13/2023
4:01 PM		NovaBay Pharmaceuticals (Issuer)
NovaBay Pharmaceuticals, Inc. (Issuer)
WU MIJIA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2023
4:02 PM		NovaBay Pharmaceuticals (Issuer)
NovaBay Pharmaceuticals, Inc. (Issuer)
Sit Swan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2023
4:02 PM		NovaBay Pharmaceuticals (Issuer)
NovaBay Pharmaceuticals, Inc. (Issuer)
Zheng Yongxiang (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2023
4:03 PM		NovaBay Pharmaceuticals (Issuer)
NovaBay Pharmaceuticals, Inc. (Issuer)
Zheng Yenyou (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2023
4:04 PM		Garlikov Julie (Reporting)
NovaBay Pharmaceuticals (Issuer)
NovaBay Pharmaceuticals, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2023
4:04 PM		Freiman Paul E. (Reporting)
NovaBay Pharmaceuticals (Issuer)
NovaBay Pharmaceuticals, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2023
11:15 PM		NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form EFFECT
06/08/2023
11:15 PM		NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form EFFECT
06/08/2023
4:22 PM		NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form 424B3
06/08/2023
4:23 PM		NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form 424B3
05/31/2023
3:49 PM		NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form S-1
Registration statement under Securities Act of 1933  
05/31/2023
3:16 PM		NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form 424B3
05/22/2023
11:15 PM		NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form EFFECT
05/18/2023
4:15 PM		NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form D
Notice of Exempt Offering of Securities 
05/18/2023
6:00 AM		NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form DEF 14A
05/18/2023
6:18 AM		NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form ARS
05/15/2023
5:52 PM		NovaBay Pharmaceuticals (Issuer)
NovaBay Pharmaceuticals, Inc. (Issuer)
Zheng Yongxiang (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2023
5:53 PM		Garlikov Julie (Reporting)
NovaBay Pharmaceuticals (Issuer)
NovaBay Pharmaceuticals, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2023
5:53 PM		NovaBay Pharmaceuticals (Issuer)
NovaBay Pharmaceuticals, Inc. (Issuer)
Sit Swan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2023
5:53 PM		NovaBay Pharmaceuticals (Issuer)
NovaBay Pharmaceuticals, Inc. (Issuer)
WU MIJIA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (Ad)

The latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty.

See why the elites are pouring billions into gold.
05/15/2023
5:54 PM		NovaBay Pharmaceuticals (Issuer)
NovaBay Pharmaceuticals, Inc. (Issuer)
Zheng Yenyou (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2023
5:54 PM		Freiman Paul E. (Reporting)
NovaBay Pharmaceuticals (Issuer)
NovaBay Pharmaceuticals, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/04/2023
7:09 AM		NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form DEFA14A
05/02/2023
7:00 AM		NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies:
SEC Filings Tools:
This page (NYSEAMERICAN:NBY) was last updated on 4/28/2024 by MarketBeat.com Staff

From Our Partners
Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share
Colonial Metals
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
This AI Trade Machine Made 1,729%* (With 89% Wins)
Prosper Trading Academy
He Is Giving Away Bitcoin
Crypto Swap Profits
The A.I. story nobody is telling you (Read ASAP)
TradeSmith
Bitcoin Rockets To Record High But Buy THIS Instead
Paradigm Press
Why Big Pharma is Investing Billions in This Biotech
Behind the Markets
Jeff Bezos Just Humiliated Elon Musk
InvestorPlace